NASDAQ
Aethlon Medical, Inc. (AEMD)
♥ 342 Thanks from members
Aethlon Medical (AEMD) trades under heavy downward pressure despite clinical progress in its Australian oncology trial, advancement to Cohort 3 for the Hemopurifier, and pandemic preparedness initiatives.